Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 20, 2016 ) In the 7MM, GlobalData epidemiologists forecast that the diagnosed incident cases of HF will increase from 1,094,344 cases in 2015 to 1,400,377 cases in 2025 at an Annual Growth Rate (AGR) of 2.80%. In the 7MM, GlobalData epidemiologists forecast that the diagnosed prevalent cases of chronic HF will increase from 13,756,453 cases in 2015 to 16,105,489 cases in 2025 at an AGR of 1.71%. The US will have the highest number of diagnosed incident cases of HF and diagnosed prevalent cases of chronic HF among the 7MM throughout the forecast period with 1,052,831 diagnosed incident cases of HF and 6,170,142 diagnosed prevalent cases of chronic HF in 2025. In the 7MM in 2015, 37.59% of the diagnosed prevalent cases of chronic HF are in NYHA Class I, 39.54% in NYHA Class II, 19.11% in NYHA Class III, and 3.75% in NYHA Class IV.
GlobalData epidemiologists utilized comprehensive, country-specific data from national HF registers and peer-reviewed journal articles to arrive at a meaningful, in-depth analysis and forecast for the diagnosed incident cases of HF, as well as the diagnosed prevalent cases of chronic HF. In this analysis, GlobalData epidemiologists provide detailed, clinically relevant segmentations for diagnosed incident and diagnosed prevalent cases of HF. Finally, the same forecast methodology was used across the 7MM, thereby allowing for meaningful global comparisons of the diagnosed incident and diagnosed prevalent cases of HF across these markets.
Request sample at : https://marketreportscenter.com/request-sample/285599
Table of Content
1 Table of Contents 1 Table of Contents 5 1.1 List of Tables 6 1.2 List of Figures 7 2 Epidemiology 9 2.1 Disease Background 9 2.2 Risk Factors and Comorbidities 10 2.3 Global Trends 12 2.3.1 US 12 2.3.2 5EU 13 2.3.3 Japan 14 2.4 Forecast Methodology. 15 2.4.1 Sources Used Tables 17 2.4.2 Forecast Assumptions and Methods 20 2.4.3 Sources Not Used 35 2.5 Epidemiological Forecast for HF (2015-2025) 36 2.5.1 Diagnosed Incident Cases 36 2.5.2 Diagnosed Prevalent Cases 49 2.6 Discussion 61 2.6.1 Epidemiological Forecast Insight 61 2.6.2 Limitations of the Analysis 61 2.6.3 Strengths of the Analysis 62 3 Appendix 63 3.1 Bibliography 63 3.2 About the Authors 72 3.2.1 Epidemiologists 72 3.2.2 Reviewers 72 3.2.3 Global Director of Therapy Analysis and Epidemiology 73 3.2.4 Global Head of Healthcare 74 3.3 About GlobalData 75 3.4 About EpiCast 75 3.5 Disclaimer 76
Check for Discount at : https://marketreportscenter.com/request-discount/285599
Scope
- The Heart Failure (HF) EpiCast Report provides an overview of the risk factors and global trends of HF in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiology forecast of HF diagnosed incident and diagnosed prevalent cases segmented by age and sex. Diagnosed incident cases are further segmented by ejection fraction, ventricular dysfunction, acute HF hospitalizations (by worsening HF, advanced HF, de novo HF), re-admissions (within 3 months) post-discharge after acute HF hospitalization, and hospital length of stay for acute HF hospitalization in these seven markets. Diagnosed prevalent cases are further segmented by chronic HF (by ejection fraction), and also classified according to the New York Heart Association (NYHA) functional classes I-IV, and American College of Cardiology Foundation/American Heart Association (ACCF/AHA) stages B, C and D in these seven markets. - The HF epidemiology report is written and developed by Masters- and PhD-level epidemiologists. - The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM. Browse full report with TOC :
Connect for more details: https://marketreportscenter.com/reports/285599/epicast-report-heart-failure-epidemiology-forecast-to-2025 Sam Collins Market Reports Center Call us : 1-646-883-3044 (US) Email : info@marketreportscenter.com
Market Reports Center
Sam Collins
1-646-883-3044
sam@marketreportscenter.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|